[ad_1] A closely watched clinical trial of a potential Alzheimer’s drug failed to prevent or slow cognitive decline; this was another disappointment in the long and arduous efforts to findRead More
Tag: Drug
Enhertu Breast Cancer Drug Results ‘Unheard of’ Survival Rates
[ad_1] Patients had metastatic breast cancer that progressed despite rigorous rounds of chemotherapy. But treatment with a drug that targets cancer cells with laser-like precision has been surprisingly successful, slowingRead More
Patients Taking Experimental Obesity Drug Gave Over 50 Pounds,
[ad_1] An experimental drug has allowed people with obesity or overweight to lose about 22.5 percent of their body weight, an average of about 52 pounds, the drug maker announcedRead More
Scientists Question the Data Behind an Experimental Alzheimer’s Drug
[ad_1] “There is no possibility, no logical way for this to happen,” he said. Elisabeth Bik, a leading expert In image manipulation, short sellers became aware of the company lastRead More
New Drug Reduces Deaths Among Severe Covid Patients, Manufacturer Claims
[ad_1] Dr. The drug was given so-called fast track status by the Food and Drug Administration in January, Steiner said. The identification aims to enable faster development and review ofRead More
In a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
[ad_1] In the interview, Mr. Johns repeated these statements. When asked if association officials have contacted Biogen since Medicare’s recommendation, he said, “I think some of our friends had aRead More
FDA’s Accelerated Drug Approvals Under Review
[ad_1] When Brittany Bonds gave birth to her third son in the back of an ambulance 10 weeks before her due date, she no longer trusted the Makena medication. TheRead More
Streamlining drug launches with data and analytics
[ad_1] Thank you for joining us on “Cloud hub: From cloud chaos to clarity”. Pharmaceutical companies recognize the need for focused and better segmented targeting for successful product launches. BuildingRead More
Medicare Recommends Sharply Limiting Alzheimer’s Drug Coverage
[ad_1] Medicare’s coverage decision is considered crucial to the future of Aduhelm, which is priced at $28,200 per patient per year. About 80 percent of patients eligible for medication areRead More
A U.S. Food and Drug Administration panel voted to recommend:
[ad_1] News: A U.S. Food and Drug Administration panel voted 13 to 10 to recommend that the government authorize Merck’s antiviral pill for high-risk covid-19 patients. The drug, called molnupiravir,Read More